These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 32067032)

  • 41. Increased infant human immunodeficiency virus-type one free survival at one year of age in sub-saharan Africa with maternal use of highly active antiretroviral therapy during breast-feeding.
    Marazzi MC; Nielsen-Saines K; Buonomo E; Scarcella P; Germano P; Majid NA; Zimba I; Ceffa S; Palombi L
    Pediatr Infect Dis J; 2009 Jun; 28(6):483-7. PubMed ID: 19483516
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A prospective study of mother-to-infant HIV transmission in tribal women from India.
    Kumar RM; Uduman SA; Khurranna AK
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul; 9(3):238-42. PubMed ID: 7788422
    [TBL] [Abstract][Full Text] [Related]  

  • 43. National estimates and risk factors associated with early mother-to-child transmission of HIV after implementation of option B+: a cross-sectional analysis.
    Tippett Barr BA; van Lettow M; van Oosterhout JJ; Landes M; Shiraishi RW; Amene E; Schouten E; Wadonda-Kabondo N; Gupta S; Auld AF; Kalua T; Jahn A
    Lancet HIV; 2018 Dec; 5(12):e688-e695. PubMed ID: 30467022
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surveillance of mother-to-child transmission prevention programmes at immunization clinics: the case for universal screening.
    Rollins N; Little K; Mzolo S; Horwood C; Newell ML
    AIDS; 2007 Jun; 21(10):1341-7. PubMed ID: 17545711
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HIV infection and zidovudine use in childbearing women.
    Sia J; Paul S; Martin RM; Cross H
    Pediatrics; 2004 Dec; 114(6):e707-12. PubMed ID: 15545619
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Implementation of prevention of mother-to-child transmission (PMTCT) in South Africa: outcomes from a population-based birth cohort study in Paarl, Western Cape.
    Pellowski J; Wedderburn C; Stadler JAM; Barnett W; Stein D; Myer L; Zar HJ
    BMJ Open; 2019 Dec; 9(12):e033259. PubMed ID: 31843848
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Active pediatric HIV case finding in Kenya and Uganda: A look at missed opportunities along the prevention of mother-to-child transmission of HIV (PMTCT) cascade.
    Gill MM; Natumanya EK; Hoffman HJ; Okomo G; Taasi G; Guay L; Masaba R
    PLoS One; 2020; 15(6):e0233590. PubMed ID: 32484815
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neurodevelopmental effects of ante-partum and post-partum antiretroviral exposure in HIV-exposed and uninfected children versus HIV-unexposed and uninfected children in Uganda and Malawi: a prospective cohort study.
    Boivin MJ; Maliwichi-Senganimalunje L; Ogwang LW; Kawalazira R; Sikorskii A; Familiar-Lopez I; Kuteesa A; Nyakato M; Mutebe A; Namukooli JL; Mallewa M; Ruiseñor-Escudero H; Aizire J; Taha TE; Fowler MG
    Lancet HIV; 2019 Aug; 6(8):e518-e530. PubMed ID: 31122797
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Perinatal HIV infection and the effect of zidovudine therapy on transmission in rural and urban counties.
    Fiscus SA; Adimora AA; Schoenbach VJ; Lim W; McKinney R; Rupar D; Kenny J; Woods C; Wilfert C
    JAMA; 1996 May; 275(19):1483-8. PubMed ID: 8622222
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants.
    Williams PL; Crain MJ; Yildirim C; Hazra R; Van Dyke RB; Rich K; Read JS; Stuard E; Rathore M; Mendez HA; Watts DH;
    JAMA Pediatr; 2015 Jan; 169(1):48-55. PubMed ID: 25383770
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [12-months efficacy of option B+ for prevention of mother-to-child transmission of HIV in Yaoundé, Cameroon].
    Njom Nlend AE; Nguedou Marcelle K; Koki Ndombo P; Brunelle Sandié A
    Rev Epidemiol Sante Publique; 2019 May; 67(3):163-167. PubMed ID: 30992178
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neurodevelopmental impairment among infants born to mothers infected with human immunodeficiency virus and uninfected mothers from three peri-urban primary care clinics in Harare, Zimbabwe.
    Kandawasvika GQ; Ogundipe E; Gumbo FZ; Kurewa EN; Mapingure MP; Stray-Pedersen B
    Dev Med Child Neurol; 2011 Nov; 53(11):1046-52. PubMed ID: 22014323
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The impact of maternal highly active antiretroviral therapy and short-course combination antiretrovirals for prevention of mother-to-child transmission on early infant infection rates at the Mulago national referral hospital in Kampala, Uganda, January 2007 to May 2009.
    Namukwaya Z; Mudiope P; Kekitiinwa A; Musoke P; Matovu J; Kayma S; Salmond W; Bitarakwate E; Mubiru M; Maganda A; Galla M; Byamugisha J; Fowler MG
    J Acquir Immune Defic Syndr; 2011 Jan; 56(1):69-75. PubMed ID: 21099692
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictors and impact of losses to follow-up in an HIV-1 perinatal transmission cohort in Malawi.
    Ioannidis JP; Taha TE; Kumwenda N; Broadhead R; Mtimavalye L; Miotti P; Yellin F; Contopoulos-Ioannidis DG; Biggar RJ
    Int J Epidemiol; 1999 Aug; 28(4):769-75. PubMed ID: 10480709
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of Senegal's prevention of mother to child transmission of HIV (PMTCT) program data for HIV surveillance.
    Diouf O; Gueye-Gaye A; Sarr M; Mbengue AS; Murrill CS; Dee J; Diaw PO; Ngom-Faye NF; Diallo PAN; Suarez C; Gueye M; Mboup A; Toure-Kane C; Mboup S
    BMC Infect Dis; 2018 Nov; 18(1):588. PubMed ID: 30453945
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Factors associated with mother to child transmission of HIV despite overall low transmission rates in HIV-exposed infants in rural Kenya.
    Okoko NA; Owuor KO; Kulzer JL; Owino GO; Ogolla IA; Wandera RW; Bukusi EA; Cohen CR; Abuogi LL
    Int J STD AIDS; 2017 Oct; 28(12):1215-1223. PubMed ID: 28181860
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
    Connor EM; Sperling RS; Gelber R; Kiselev P; Scott G; O'Sullivan MJ; VanDyke R; Bey M; Shearer W; Jacobson RL
    N Engl J Med; 1994 Nov; 331(18):1173-80. PubMed ID: 7935654
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An audit of mother to child HIV transmission rates and neonatal outcomes at a tertiary hospital in South Africa.
    Benali G; Ramdin T; Ballot D
    BMC Res Notes; 2019 Sep; 12(1):586. PubMed ID: 31533837
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outcomes and linkage to chronic care of HIV exposed infants among health centers and hospitals in Amhara Region, Ethiopia: implications to prevention of mother-to-child transmission of HIV program: a cross sectional study.
    Kebede ZT; Taye BW
    Pan Afr Med J; 2016; 24():61. PubMed ID: 27642402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.